WHYUS
We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.
NewsEvents
On March 29-April 3, Carlo Toniatti (CSO) and Dan Conlon (VP of Business Development, North America) will be attending AACR…
EASL 2019
On April 10-14, Vincenzo Summa (VP Drug Discovery), Leda Bencheva (Research Scientist) will be attending EASL 2019 in Vienna, Austria.…
World Vaccine Congress
On April 14-17, Stefania di Marco (Qualified Person, ADVENT), Dan Conlon (VP of Business Development, North America) will represent ADVENT,…
Swiss Biotech Day 2019
On May 7, Pier Giorgio Pacifici (Business Development Manager) will be attending Swiss Biotech Day 2019 in Basel, Switzerland. To…
IRBMPHOTOS
